Abstract

IntroductionMicrovasculopathy is characterized by progressive structural and functional damage to the microvessels and plays a key role in the pathogenesis of various connective tissue diseases (CTD). Nailfold videocapillaroscopy is an optimal and validated method for analysis of microvascular abnormalities and is able to differentiate secondary Raynaud’s phenomenon (RP) of CTD from primary RP and healthy subjects.AimTo assess and analyze nailfold capillaroscopic findings in Indian subjects with secondary Raynaud and to compare with findings in healthy subjects.MethodsA total of 62 study participants including cases and controls underwent nailfold videocapillaroscopy. Capillary loop length, capillary width, capillary density, presence/absence of tortuosity, giant loops, neoangiogenesis, microhemorrhages, and avascular areas were the parameters studied.ResultsAll the quantitative and qualitative parameters studied were significantly associated with secondary RP. Mean loop length in cases of connective tissue diseases was significantly less than in the controls (225.74 μm versus 282.97 μm) (P=0.002). Capillary density was also reduced significantly in the cases as compared to the controls (4.6 versus 7.39/mm) (P<0.01), whereas it was markedly decreased in systemic sclerosis (SSc) and mixed connective tissue diseases (MCTD), and near normal in systemic lupus erythematosus (SLE). Tortuosity was the most frequent (77.4%) qualitative parameter. Scleroderma pattern was found in 62.5% of patients with SSc and in 60% with MCTD. Non-specific pattern was found in 80% of SLE cases and 50% of dermatomyositis cases.ConclusionBoth quantitative and qualitative capillaroscopic changes are significantly associated with secondary RP. Scleroderma pattern was predominant in SSc and MCTD, whereas non-specific pattern was predominantly found in SLE and dermatomyositis.

Highlights

  • Carbapenem-resistant Enterobacterales (CRE) are amongst the major challenges that have been facing healthcare institutions throughout the world in the last two decades.[1]

  • In 2014, 94% (89/95) of all carbapenemaseproducing Enterobacterales (CPE) acquired at Rambam Health Care Campus (RHCC) possessed the Klebsiella pneumoniae carbapenemase (KPC) gene

  • The proportion of New Delhi metallo-β-lactamase (NDM) and OXA-48 increased to 29% (39/134) and 12.7% (17/ 134), respectively (Table 1)

Read more

Summary

Introduction

Carbapenem-resistant Enterobacterales (CRE) are amongst the major challenges that have been facing healthcare institutions throughout the world in the last two decades.[1] Carbapenem resistance among CRE is mediated most commonly by broad-spectrum β-lactamases that hydrolyze and inactivate the βlactam ring of all known β-lactams, including the last-resort carbapenems. These broad-spectrum enzymes are labeled carbapenemases, and the CRE producing these are named carbapenemaseproducing Enterobacterales (CPE). The most common currently known carbapenemases include Klebsiella pneumoniae carbapenemase (KPC), New Delhi metallo-β-lactamase (NDM), imipenemase (IMI), oxacillinases (OXA)-48, and Verona integronencoded metallo-β-lactamase (VIM). The spread of CRE was contained.[2]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call